GB9715490D0 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
GB9715490D0
GB9715490D0 GBGB9715490.0A GB9715490A GB9715490D0 GB 9715490 D0 GB9715490 D0 GB 9715490D0 GB 9715490 A GB9715490 A GB 9715490A GB 9715490 D0 GB9715490 D0 GB 9715490D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9715490.0A
Other versions
GB2315673A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617896.7A external-priority patent/GB9617896D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9715490D0 publication Critical patent/GB9715490D0/en
Publication of GB2315673A publication Critical patent/GB2315673A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9715490A 1996-08-01 1997-07-23 Treatment of migraine Withdrawn GB2315673A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2289996P 1996-08-01 1996-08-01
GBGB9617896.7A GB9617896D0 (en) 1996-08-28 1996-08-28 Pharmaceutical preparation

Publications (2)

Publication Number Publication Date
GB9715490D0 true GB9715490D0 (en) 1997-10-01
GB2315673A GB2315673A (en) 1998-02-11

Family

ID=26309929

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9715490A Withdrawn GB2315673A (en) 1996-08-01 1997-07-23 Treatment of migraine

Country Status (1)

Country Link
GB (1) GB2315673A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115353492A (en) * 2022-08-26 2022-11-18 浙江野风药业股份有限公司 Method for continuously synthesizing 1- (4-hydrazinophenyl) methyl-1, 2,4-triazole

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
IL134087A0 (en) * 1997-07-21 2001-04-30 Astra Ab Composition, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
GB9928578D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations
WO2001043733A2 (en) * 1999-12-15 2001-06-21 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
DE10035865C2 (en) * 2000-07-24 2003-02-06 Norbert Over Use of aqueous spray solutions of the local anesthetic agent lidocaine for the prophylactic treatment of migraines
DE10118306A1 (en) * 2001-04-12 2002-10-17 Bayer Ag Composition for intranasal administration of imidazo-triazinone derivative cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption
EP1709032A2 (en) 2004-01-09 2006-10-11 Ratiopharm GmbH Crystalline forms of rizatriptan benzoate
ZA200704869B (en) * 2004-12-23 2009-02-25 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac
WO2006082598A2 (en) * 2005-02-01 2006-08-10 Natco Pharma Limited Novel crystalline forms of rizatriptan benzoate
CA2688463A1 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Process for the preparation of rizatriptan
US8277781B2 (en) 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8551454B2 (en) 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US9789071B2 (en) * 2012-06-27 2017-10-17 G2B Pharma, Inc. Intranasal formulation of epinephrine for the treatment of anaphylaxis
BR112018015367A2 (en) 2016-01-27 2018-12-18 Instar Tech A S nanofiber oromucosal carriers for therapeutic treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115353492A (en) * 2022-08-26 2022-11-18 浙江野风药业股份有限公司 Method for continuously synthesizing 1- (4-hydrazinophenyl) methyl-1, 2,4-triazole

Also Published As

Publication number Publication date
GB2315673A (en) 1998-02-11

Similar Documents

Publication Publication Date Title
GB9602080D0 (en) Pharmaceutical compounds
CZ20011518A3 (en) Pharmaceutical preparation
AP9500733A0 (en) Pharmaceutical formulations
HUP9901674A3 (en) New pharmaceutical combination
GB9715490D0 (en) Pharmaceutical preparation
GB9609976D0 (en) Pharmaceutical compounds
EP0907644A4 (en) Pharmaceutical preparation
ZA976189B (en) Oral pharmaceutical combinations
GB9621789D0 (en) Pharmaceutical compounds
GB9604736D0 (en) A pharmaceutical preparation
ZA982073B (en) Pharmaceutical preparation
GB9408053D0 (en) Pharmaceutical preparation
EP0923564A4 (en) Pharmaceutical compounds
ZA979329B (en) Pharmaceutical compounds
AP9801196A0 (en) Pharmaceutical preparation
GB9623962D0 (en) Pharmaceutical composition
GB9626151D0 (en) Pharmaceutical compounds
ZA967542B (en) Pharmaceutical combination preparation comprising keto-profen
ZA952013B (en) Pharmaceutical preparation
GB9617896D0 (en) Pharmaceutical preparation
GB9617894D0 (en) Pharmaceutical preparation
GB9604108D0 (en) Pharmaceutical preparation
GB9607890D0 (en) Pharmaceutical preparation
GB9606019D0 (en) Pharmaceutical preparation
AU4948297A (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)